New drug combo shrinks tumors in most patients facing aggressive cancer type
The pancreatic cancer pill daraxonrasib shrank tumors in 60.7% of patients when paired with chemotherapy, with 8.2% seeing tumors vanish on scans.
FOX News
Full text, translation and AI summary — after signing in
- The full article in your language
- AI summary and translation from the original
- The same account works in the Suviy app
Comments
Sign in to join the conversation. Sign in
No comments yet.